North Capital’s MetLife MET Stock Holding History

North Capital’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-331	Closed	-$27.3K	–	459
2025 Q3	$27.3K	Buy	331 +1	+0.3%	+$79	0.02%	278
2025 Q2	$26.5K	Hold	330	–	–	0.02%	276
2025 Q1	$26.5K	Buy	+330	New	+$27.4K	0.03%	268

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

North Capital's MET Position: Q4 2025 in Review

North Capital sold out of MetLife (MET) in Q4 2025, closing a stake of 331 shares — an estimated $27.3K sold.

North Capital first reported a position in MET in Q1 2025 and held it in 3 quarters. The position peaked at $27.3K in Q3 2025. 1,446 funds tracked by Wall St. Rank hold MET as of Q4 2025.

North Capital reported no remaining MetLife position as of Q4 2025 after selling out during the quarter.
North Capital sold 331 MetLife shares in Q4 2025, an estimated $27.3K.
North Capital first reported a position in MetLife in Q1 2025 and held it in 3 quarters.
North Capital's MetLife position peaked at $27.3K in Q3 2025.
1,446 funds tracked by Wall St. Rank held MetLife as of Q4 2025.

Based on North Capital's 13F filing for Q4 2025, filed 18 Feb 2026.